MIRA INFORM REPORT

 

 

Report No. :

316718

Report Date :

15.04.2015

 

IDENTIFICATION DETAILS

 

Name :

AMSTELFARMA B.V.

 

 

Registered Office :

Zuiveringweg 40, 8243PZ Lelystad

 

 

Country :

Netherlands

 

 

Financials (as on) :

31.12.2013

 

 

Date of Incorporation :

01.11.1986

 

 

Com. Reg. No.:

39064879

 

 

Legal Form :

Private Company

 

 

Line of Business :

·         Manufacture of plastics in primary forms

·         Agents involved in the sale of fuels

·         Wholesale of basic and industrial chemicals

 

 

No. of Employees :

35

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

No Complaints

Litigation :

Clear

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – December 31, 2014

 

Country Name

Previous Rating

(30.09.2014)

Current Rating

(31.12.2014)

Netherlands

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

NETHERLANDS - ECONOMIC OVERVIEW

 

Netherlands, the sixth-largest economy in the euro-zone, is noted for its important role as a European transportation hub, sizable trade surplus, stable industrial relations, and moderate unemployment and inflation. Industry focuses on food processing, chemicals, petroleum refining, and electrical machinery. A highly mechanized agricultural sector employs only 2% of the labor force but provides large surpluses for food-processing and export. Netherlands, along with 11 of its EU partners, began circulating the euro currency on 1 January 2002. The Dutch financial sector suffered as a result of the global financial crisis, due in part to the high exposure of some Dutch banks to US mortgage-backed securities. In 2008, the government injected billions of dollars of capital into financial institutions to stem the deterioration. To address the economic downturn, the government also sought to stimulate the domestic economy by accelerating infrastructure programs, offering corporate tax breaks for employers to retain workers, and expanding export credits. The stimulus programs and bank bailouts, however, resulted in a government budget deficit of 5.3% of GDP in 2010 that contrasted sharply with a surplus of 0.7% in 2008. The government of Prime Minister Mark RUTTE began implementing austerity measures in early 2011 to reduce the budget deficit, and, in 2013, the government brought the budget deficit below the euro-zone limit of 3% of GDP. Though the Dutch economy remains fragile, a gradual improvement in GDP growth in 2014 helped reduce the deficit further through an increase in government tax revenues. Private consumption remains subdued because of high unemployment, low wage growth, and still-high levels of debt, which together with tax increases, have made households reluctant to spend. Private investment and export growth are susceptible to slower activity in the Netherlands’ European trading partners and geopolitical tensions that constrain international trade.

 

Source : CIA

 

Summary

 

Company name                        Amstelfarma B.V.

Operative address                    Zuiveringweg 40

8243PZ Lelystad

Netherlands

Legal form                               Private Company

Registration number                KvK-nummer: 39064879

VAT-number                             008620751

 

Year

 

2013

Mutation

2012

Fixed assets

82.116

-15,12

96.741

Total receivables

4.410.577

10,09

4.006.462

Total equity

1.117.193

149,77

447.293

Short term liabilities

3.352.052

-8,32

3.656.110

Working capital

1.059.077

202,12

350.552

Quick ratio

1,32

20,00

1,10

 

 

 

 

 

Contact information

 

Company name                        Amstelfarma B.V.

Trade names                            Amstelfarma

Amstelfarma B.V.

Operative address                    Zuiveringweg 40

8243PZ Lelystad

Netherlands

Correspondence address         Postbus 2200

8203AE Lelystad

Netherlands

Telephone number                   0320295040

Fax number                              0320219655

Email address                          info@amstelfarma.nl

Website                                    www.amstelfarma.nl

 

 

Registration

 

Registration number                KvK-nummer: 39064879

Branch number                        000008488819

VAT-number                             008620751

Status                                      Active

Memorandum                           1986-12-29

Establishment date                  1986-11-01

Legal form                               Besloten Vennootschap

Last proposed admendment     1992-04-14

Issued placed capital               EUR 68.067

Paid up share capital               EUR 68.067

 

 

Activities

 

SBI                                           Manufacture of plastics in primary forms (2016)

Agents involved in the sale of fuels (4612)

Wholesale of basic and industrial chemicals (46751)

Exporter                                   Yes

Importer                                   Yes

Goal                                         Wholesale of raw materials and products in general and in chemical raw materials and products in particular; as well as the conduct of agencies and representations to the point; also holder of a production license . Pharmaceutical wholesaler.

 

 

Relations

 

Shareholders                           Amstelfarma Holding B.V.

Nijverheidsweg 37

2102LK HEEMSTEDE

 

Netherlands

Registration number: 558243900000

Percentage: 100%

Branches                                  Amstelfarma B.V.

Nijverheidsweg 37

2102LK HEEMSTEDE

Netherlands

Registration number: 390648790001

 

Amstelfarma BV

Registration number: 340784650000

Meergoed B.V.

Registration number: 390648880000

Meergoed BV

Registration number: 340989730000

Meervliet Beheer B.V.

Registration number: 390648810000

Meervliet Beheer BV

Registration number: 340890850000

Quality Support BV

Registration number: 340901520000

Quality Support B.V.

Registration number: 390648820000

Roozendaal Van den Brink BV

Registration number: 340740780000

Waterland Laboratories B.V.

Registration number: 390648660000

Companies on same address

Waterland Laboratories BV

Registration number: 340745400000

 

Liability statements                  Meervliet Beheer B.V.

Zuiveringweg 40

8243PZ LELYSTAD

Netherlands

Registration number: 390648810000

date of issue: 2006-01-26

Starting date: 2005-01-01

End date: 2012-09-14

 

Bank details

 

Accounts                                  ABN Amro Bank NV

Account number: NL11ABNA0410657913

 

 

Management

 

Active management                  Bogers Management B.V.

Nooit Gedacht 98

1398EG Muiden

Netherlands

Registration number: 341372080000

Competence: Fully authorized

Function: Manager

Starting date: 2012-09-25

J. Hoekstra - Voogd (Josine)

Netherlands

Competence: Limited authorization

Function: Manager

Starting date: 2011-09-01

Date of birth: 1978-03-17, Heemskerk, NL

 

J.J.M. van Haperen (Johannes Jacobus Maria)

Netherlands

Competence: Limited authorization

Function: Proxy

Starting date: 2012-09-25

Date of birth: 1957-05-08, Breda, NL

 

 

Employees

 

Total according to the Chamber of Commerce

35

 

 

 

 

 

 

 

 

 

 

Year

 

2014

2013

2012

2011

2008

Total

35

21

14

14

14

 

 

 

 

Payments

 

Description Payments are made regularly no complaints are known

 

Key Figures

 

Year

 

2013

2012

Quick ratio

1,32

1,10

Current ratio

1,32

1,10

Working capital/ balance total

0,24

0,09

Equity / balance total

0,25

0,11

Equity / Fixed assets

13,61

4,62

Equity / liabilities

0,33

0,12

Balance total / liabilities

1,33

1,12

Working capital

1.059.077

350.552

Equity

1.117.193

447.293

 

Year

2013

2012

Mutation equity

149,77

 

Mutation short term liabilities

-8,32

 

 

Summary

 

The 2013 financial result structure is a postive working captial of 1.059.077 euro, which is in

agreement with 24 % of the total assets of the company.

The working capital has increased with 202.12 % compared to previous year. The ratio, with

respect to the total assets of the company has however, increased.

The improvement between 2012 and 2013 has mainly been caused by an increase of the

current assets.

The current ratio of the company in 2013 was 1.32. When the current ratio is below 1.5, the

company may have problems meeting its short-term obligations.

The quick ratio in 2013 of the company was 1.32. A company with a Quick Ratio of more than

1 can currently pay back its current liabilities.

The 2012 financial result structure is a postive working captial of 350.552 euro, which is in

agreement with 9 % of the total assets of the company.

The current ratio of the company in 2012 was 1.1. When the current ratio is below 1.5, the

company may have problems meeting its short-term obligations.

The quick ratio in 2012 of the company was 1.1. A company with a Quick Ratio of more than

1 can currently pay back its current liabilities.

 

 

 

 

Financial statement

 

Last annual account                 2013

Remark annual account            The company is obliged to file its financial statements.

Type of annual account            Corporate

 

Annual account                        Amstelfarma B.V.

Zuiveringweg 40

8243PZ Lelystad

Netherlands

Registration number: 390648790000

 

Balance

 

Year

 

2013

2012

End date

2013-12-31

2012-12-31

Other tangible fixed assets

82.116

96.741

Tangible fixed assets

82.116

96.741

Fixed assets

82.116

96.741

Other receivables

4.410.577

4.006.462

Total receivables

4.410.577

4.006.462

Liquid funds

552

200

accruals

4.410.577

4.006.462

Current assets

4.411.129

4.006.662

Total assets

4.493.245

4.103.403

Issued capital

68.067

68.067

Other reserves

1.049.126

379.226

Total reserves

1.049.126

379.226

Total equity

1.117.193

447.293

Provisions

24.000

 

Short term liabilities

3.352.052

3.656.110

Total short and long term liabilities

3.376.052

3.656.110

Total liabilities

4.493.245

4.103.403

 

Summary

 

The total assets of the company increased with 9.5 % between 2012 and 2013.

Despite the assets growth, the non current assets decreased with -15.12 %.

The assets growth has been financed by a Net Worth increase of 149.77 %. The company's

net increase has also covered a reduction of -7.66 % of the company's indebtedness.

In 2013 the assets of the company were 1.83 % composed of fixed assets and 98.17 % by

current assets. The assets are being financed by an equity of 24.86 %, and total debt of

75.14 %.

In 2012 the assets of the company were 2.36 % composed of fixed assets and 97.64 % by

current assets. The assets are being financed by an equity of 10.9 %, and total debt of 89.1 %.

 

 

 

 

Analysis

 

Branch (SBI)                             MANUFACTURE OF CHEMICALS AND CHEMICAL PRODUCTS (20)

Region                                     Flevoland

In the Netherlands 1365 of the companies are registered with the SBI code 20

In the region Flevoland 41 of the companies are registered with the SBI code 20

In the Netherlands 17 of the bankrupcties are published within this sector

In the region Flevoland 1 of the bankruptcies are published within this sector

The risk of this specific sector in the Netherlands is normal

The risk of this specific sector in the region Flevoland is normal

 

 

Publications

 

Consent statements                  01-11-2012: Voor boekjaar 2011 is een instemmingsverklaring gedeponeerd.

16-05-2012: Voor boekjaar 2010 is een instemmingsverklaring gedeponeerd.

 

Liability statements                  17-09-2012: Per 14-09-2012 is een aansprakelijkheidsverklaring door Meervliet Beheer B.V. ingetrokken.

 

Filings                                                 12-05-2014: De jaarrekening over 2013 is gepubliceerd.

08-10-2013: De jaarrekening over 2012 is gepubliceerd.

 

Functions                                 15-03-2013: Per 25-09-2012 is gevolmachtigde Johannes Jacobus Maria van Haperen in functie getreden.

14-03-2013: Per 01-09-2011 is gevolmachtigde Josine Hoekstra-Voogd in functie getreden.

28-09-2012: Per 25-09-2012 is bestuurder 34137208 Bogers Management B.V. in functie getreden.

28-09-2012: Per 25-09-2012 is bestuurder Johan Lambert van den Brink uit functie getreden.

28-09-2012: Per 25-09-2012 is gevolmachtigde Nicolaas Cornelis Theodorus Roozendaal uit functie getreden.

28-09-2012: Per 25-09-2012 is gevolmachtigde Josine Hoekstra-Voogd uit functie getreden.

28-09-2012: Per 25-09-2012 is gevolmachtigde Johannes Jacobus Maria van Haperen uit

 

functie getreden.

15-11-2011: Per 01-09-2011 is bestuurder Nicolaas Cornelis Theodorus Roozendaal uit

functie getreden.

15-11-2011: Per 01-09-2011 is gevolmachtigde Johan Lambert van den Brink uit functie

getreden.

04-11-2011: Per 01-09-2011 is gevolmachtigde Nicolaas Cornelis Theodorus Roozendaal in

functie getreden.

04-11-2011: Per 01-09-2011 is bestuurder Johan Lambert van den Brink in functie getreden.

 

Amendments                            08-12-2011: Per 1-9-2011 is de bevoegdheid van Bestuurder Johan Lambert van den Brink gewijzigd.

 

 

Company structure

 

Relations                                  4

 

Bogers Management B.V.

Nooit Gedacht 98

1398EG Muiden

Netherlands

Registration number: 341372080000

 

• Amstelfarma Holding B.V.

Nijverheidsweg 37

2102LK HEEMSTEDE

Netherlands

Registration number: 558243900000

 

• Amstelfarma B.V.

Zuiveringweg 40

8243PZ Lelystad

Netherlands

Registration number: 390648790000

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.62.39

UK Pound

1

Rs.91.05

Euro

1

Rs.66.16

 

 

INFORMATION DETAILS

 

Analysis Done by :

RAS

 

 

Report Prepared by :

TPT

 

               


 

RATING EXPLANATIONS

 

RATING

STATUS

PROPOSED CREDIT LINE

 

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

 

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

 

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

 

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

 

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

 

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

 

--

NB

New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.